
Inhaled siRNA-Based MIR 19 Reduces Progression to Severe Disease in Outpatients With Mild COVID-19
MIR 19 (siR-7-EM/KK-46), a small interfering RNA (siRNA) inhaled treatment targeting SARS-CoV-2—the virus that causes COVID-19—was found to meaningfully decrease the progression to moderate or severe disease in outpatients with mild COVID-19 while …